Provided by Tiger Fintech (Singapore) Pte. Ltd.

Altamira Therapeutics Ltd.

0.3000
0.0000
Volume:- -
Turnover:- -
Market Cap:1.13M
PE:-0.16
High:0.3000
Open:0.3000
Low:0.3000
Close:0.3000
52wk High:3.60
52wk Low:0.3000
Shares:3.78M
Float Shares:3.76M
Volume Ratio:- -
T/O Rate:- -
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.9065
EPS(LYR):-9.3533
ROE:-368.78%
ROA:-57.15%
PB:0.18
PE(LYR):-0.03

Loading ...

Jun 01, 2023

Public Prospectus

Form F-1 - Registration statement for certain foreign private issuers
May 16, 2023

Annual Report

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
Apr 27, 2023

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Apr 11, 2023

[Supp]Public Prospectus

FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
Mar 31, 2023

Correspondence

CORRESP [Cover] - Correspondence
Mar 31, 2023

Correspondence

CORRESP [Cover] - Correspondence
Mar 31, 2023

Correspondence

CORRESP [Cover] - Correspondence
Mar 31, 2023

Correspondence

CORRESP [Cover] - Correspondence
Mar 27, 2023

[Amend]Public Prospectus

F-1/A [Amend] - Registration statement for certain foreign private issuers
Mar 23, 2023

Correspondence

CORRESP [Cover] - Correspondence
Mar 23, 2023

Correspondence

CORRESP [Cover] - Correspondence
Mar 23, 2023

Correspondence

CORRESP [Cover] - Correspondence
Mar 23, 2023

Correspondence

CORRESP [Cover] - Correspondence
Mar 23, 2023

[Amend]Public Prospectus

F-1/A [Amend] - Registration statement for certain foreign private issuers
Mar 23, 2023

[Supp]Public Prospectus

FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
Mar 17, 2023

Correspondence

CORRESP [Cover] - Correspondence
Mar 17, 2023

Correspondence

CORRESP [Cover] - Correspondence
Mar 17, 2023

Correspondence

CORRESP [Cover] - Correspondence
Mar 17, 2023

Correspondence

CORRESP [Cover] - Correspondence
Mar 13, 2023

Correspondence

CORRESP [Cover] - Correspondence